Key result
Glycyrrhizin and omega-3 fatty acids reduce liver malondialdehyde and TLR-4 expression in rats with fibrosis.
Why the study?
To investigate the hepatoprotective role of glycyrrhizin and omega-3 fatty acids against thioacetamide-induced liver fibrosis and clarify their molecular mechanism regarding oxidative stress and toll-like receptor-4.
Do glycyrrhizin and omega-3 fatty acids prevent thioacetamide-induced liver fibrosis in a rat model?
RCT (n=40)
randomized
Do glycyrrhizin and omega-3 fatty acids prevent thioacetamide-induced liver fibrosis in a rat model?
Answers are grounded in this paper and cite their sources.
Glycyrrhizin and omega-3 fatty acids demonstrate hepatoprotective, anti-inflammatory, and anti-fibrotic effects in a rat model of liver fibrosis via TLR-4 inhibition.
This study investigated the hepatoprotective role of natural compounds [glycyrrhizin (GL) and omega-3 fatty acids (ω-3)] against thioacetamide (TAA)-induced liver fibrosis and clarified their underlying molecular mechanism through their effect on oxidative stress and toll-like receptor-4 (TLR-4). Forty male Wistar rats were randomized to five groups: Control group and four groups received TAA 200 mg/kg i.p. twice weekly for 8 weeks: TAA group, TAA+GL group (received GL 25 mg/kg daily by oral tube), TAA+ω-3 group (received ω-3150 mg/kg daily by oral tube), TAA+GL+ω-3 group (received similar combined doses of both natural compounds). GL, ω-3 and their combination protected the liver from TAA-hepatotoxic effects. Their hepatoprotective effects were confirmed by histopathological analysis as they significantly reduced the necroinflammatory scores and the extent of fibrosis. They act as anti-oxidant as they significantly decreased the liver malondialdehyde level (P < 0.005). They also significantly increased liver inactive TLR-4 concentration (P < 0.005) which indicates inhibition of TLR-4 pathway. This is confirmed by a significant decrease in liver TLR-4 mRNA expression (P < 0.005). In conclusion, glycyrrhizin, omega-3 fatty acids and their combination have potent anti-inflammatory, anti-oxidant and anti-fibrotic effects through inhibition of TLR-4.
No takes yet. Share an insight, caveat, or question.
El‐Magd et al. (2019) conducted an RCT in thioacetamide (TAA)-induced liver fibrosis (n=40). Glycyrrhizin and omega-3 fatty acids vs. TAA alone and healthy control was evaluated on liver malondialdehyde level and TLR-4 expression (p=< 0.005). Glycyrrhizin, omega-3 fatty acids, and their combination decreased liver malondialdehyde levels and TLR-4 mRNA expression in rats with TAA-induced liver fibrosis.
Synapse has enriched 10 related papers. Consider them for comparative context: